Laboratorio Reig Jofre, S.A. engages in the pharmaceutical industry, focusing on the research, development, and production of medical products. The company aims to address healthcare needs through a range of pharmaceuticals and over-the-counter medications.
1929
Spain
1,001 - 5,000 employees
Pharmaceuticals
$100M - 500M in revenue
$10M - 25M in profitability
See all
Carbon emissions
Electricity consumption
Carbon certificate projects
Targets
SDG Impact

Sustainability
Report
Industry rank: 140 out of 527ⓈThe carbon emissions rank is based on a company's CO2 equivalent Scope 1 and 2 greenhouse gas emissions compared to other companies in the same industry (over 50 companies) in Illuminem's database. Higher emissions result in a lower rank.
Total CO2 emissions
(CO2e tonnes)
Industry rank: 140 out of 527ⓈThe carbon emissions rank is based on a company's CO2 equivalent Scope 1 and 2 greenhouse gas emissions compared to other companies in the same industry (over 50 companies) in Illuminem's database. Higher emissions result in a lower rank.
| Target | Year | Value | Scope | Baseline |
|---|---|---|---|---|
| Net Zero | ******* | ******* | ******* | ******* |
| Share of renewables | ******* | ******* | ******* | ******* |
Fake Job Title 1
**************
Fake Job Title 2
**************
Disclaimer: The information provided by illuminem ("we", "us") is for general informational purposes only. All information on the pages is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy of any information on the pages. The information on the pages is either provided to us directly by the companies to which the information relates, or by third-party data providers, or derives from publicly available sources. In certain instances the information might be estimations based on limited information publicly available. Your reliance on any information provided on the pages is solely at your own risk. If you believe that any information is incorrect or in breach of your rights, please contact us.